HOME › DRUGS › ORITAVANCIN
ACTIVE SUBSTANCE / INN

ORITAVANCIN

Brand name(s): Tenkasi (previously Orbactiv), Ramvocid
EMA LISTED
APPLICATION WITHDRAWN
AUTHORISED
Soft Tissue Infections;Skin Diseases, Bacterial
Gram-Positive Bacterial Infections;Skin Diseases, Bacterial;…
ACTIVE SUBSTANCE
Oritavancin
REGULATORS
EMA
SPONSORS / MAH
Targanta Netherlands B.V., Menarini International Operations Luxembourg S.A.
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Tenkasi (previously Orbactiv)Menarini International Operations Luxembourg S.A.Authorised19/03/2015Soft Tissue Infections;Skin Diseases, Bacterial
RamvocidTarganta Netherlands B.V.Application withdrawnGram-Positive Bacterial Infections;Skin Diseases, Bacterial;Soft Tissue Infectio…

FULL INTELLIGENCE ON ORITAVANCIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →